The global T-Cell Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report aims to provide a comprehensive presentation of the global market for T-Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding T-Cell Therapy. This report contains market size and forecasts of T-Cell Therapy in global, including the following market information:
- Global T-Cell Therapy Market Revenue, 2018-2023, 2024-2030, ($ millions)
- Global top five companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
CAR T Cell Therapy Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of T-Cell Therapy include Gilead Sciences, Inc., Sorrento Therapeutics, Fate Therapeutics Inc., Novartis International AG, AbbVie Inc., Adaptimmune Therapeutics PLC, Bluebird Bio, TCR2 Therapeutics, Inc. and Pfizer Inc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the T-Cell Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global T-Cell Therapy Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global T-Cell Therapy Market Segment Percentages, by Type, 2022 (%)
- CAR T Cell Therapy
- TCR Therapy
- TIL Therapy
Global T-Cell Therapy Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global T-Cell Therapy Market Segment Percentages, by Application, 2022 (%)
- Hospitals
- Clinics & Ambulatory Centers
- Cancer Research Institutes
- Others
Global T-Cell Therapy Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global T-Cell Therapy Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies T-Cell Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies T-Cell Therapy revenues share in global market, 2022 (%)
key players include:
- Gilead Sciences, Inc.
- Sorrento Therapeutics
- Fate Therapeutics Inc.
- Novartis International AG
- AbbVie Inc.
- Adaptimmune Therapeutics PLC
- Bluebird Bio
- TCR2 Therapeutics, Inc.
- Pfizer Inc.
- DiaCarta, Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of T-Cell Therapy, market overview.
Chapter 2: Global T-Cell Therapy market size in revenue.
Chapter 3: Detailed analysis of T-Cell Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of T-Cell Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
